- Home
- TBHC vs TXMD Comparison
TBHC vs TXMD Comparison
Compare TBHC & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TBHC | TXMD |
|---|---|---|
| Founded | 1966 | 2008 |
| Country | United States | United States |
| Employees | 4010 | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.9M | 24.3M |
| IPO Year | N/A | 2012 |
Fundamental Metrics
Financial Performance| Metric | TBHC | TXMD |
|---|---|---|
| Price | $0.92 | $2.07 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 45.7K | 16.6K |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 73.68 |
| EPS | N/A | ★ 0.01 |
| Revenue | N/A | ★ $1,761,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $205.00 |
| Revenue Growth | N/A | ★ 35.25 |
| 52 Week Low | $0.86 | $0.98 |
| 52 Week High | $2.40 | $2.95 |
Technical Indicators
Market Signals| Indicator | TBHC | TXMD |
|---|---|---|
| Relative Strength Index (RSI) | 42.69 | 53.35 |
| Support Level | N/A | $1.93 |
| Resistance Level | $1.27 | $2.29 |
| Average True Range (ATR) | 0.05 | 0.09 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 47.00 | 76.09 |
Price Performance
Historical ComparisonAbout TBHC The Brand House Collective Inc.
The Brand House Collective Inc is a specialty retailer of home decor and gifts in the United States. The company stores provide various merchandise, including holiday decor, value pricing, and a stimulating in-store and online environment that provides customers with a brand experience. The company stores also offer an assortment of holiday merchandise in seasonal periods, as well as items that are suitable for gift-giving.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.